SAPIRSTEIN JAMES - Insider Non-Derivative Transactions at Entero Therapeutics, Inc. (ENTO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 2, 2024, SAPIRSTEIN JAMES's relationship to Entero Therapeutics, Inc. (ENTO) is Director,Officer (Chairman and CEO), and currently has 35,816 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ENTO insiders.
Data Source: SEC.
SAPIRSTEIN JAMES - Insider Non-Derivative Transactions at ENTO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 3, 2024 | Sell -- (Common Stock) | 1289 | 1.07 | 35816 |